Vanda Pharmaceuticals Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
VNDA Nasdaq 2834 www.vandapharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Vanda Pharmaceuticals Inc.

3 Promising Penny Stocks With Market Caps Under $400M - Jun 27th, 2025 6:05 am
Vanda Pharmaceuticals Announces First Patient Dosed in a Trial Evaluating VCA-894A in Charcot-Marie-Tooth disease Type 2S - Jun 10th, 2025 6:00 am
Vanda Pharmaceuticals Announces Presentation at 2025 ASCP Annual Meeting - May 27th, 2025 7:00 am
Vanda Pharmaceuticals Announces Participation in the Mizuho Neuro & Ophthalmology Summit 2025 - May 16th, 2025 3:30 pm
Vanda Pharmaceuticals Inc (VNDA) Q1 2025 Earnings Call Highlights: Revenue Growth Amid Rising ... - May 8th, 2025 1:28 am
Vanda Pharmaceuticals (VNDA) Reports Q1 Loss, Tops Revenue Estimates - May 7th, 2025 3:10 pm
Vanda: Q1 Earnings Snapshot - May 7th, 2025 2:07 pm
Vanda Pharmaceuticals Reports First Quarter 2025 Financial Results - May 7th, 2025 2:01 pm
3 Penny Stocks Under $300M Market Cap To Consider - May 6th, 2025 6:05 am
Vanda Announces Bysanti™ NDA Filing; FDA Decision Expected in Early 2026 - May 5th, 2025 6:00 am
Vanda Pharmaceuticals to Announce First Quarter 2025 Financial Results on May 7, 2025 - May 2nd, 2025 6:46 am
FDA’s job cuts paint mixed picture for drugmakers’ R&D plans - Apr 28th, 2025 2:00 am
FDA Bureaucrats Unlawfully Delay Hearing on Vanda Drug and Falsely Blame Commissioner Makary and the reductions in force at FDA - Apr 23rd, 2025 1:52 pm
Vanda Pharmaceuticals Announces Presentation at 2025 AAN Annual Meeting - Apr 7th, 2025 6:00 am
High Growth Tech Stocks In US With Promising Potential - Apr 2nd, 2025 11:08 am
Vanda Pharmaceuticals Announces the Submission of an NDA to the FDA for Bysanti™ for the Treatments of Acute Bipolar I Disorder and Schizophrenia - Mar 31st, 2025 6:00 am
US High Growth Tech Stocks With Strong Potential - Feb 28th, 2025 10:09 am
February 2025 Penny Stocks To Keep An Eye On - Feb 27th, 2025 4:05 am
Vanda Pharmaceuticals announces the publication of an article titled "Potential ASO-based personalized treatment for Charcot-Marie-Tooth disease type 2S" - Feb 24th, 2025 5:00 am
Vanda Pharmaceuticals Inc (VNDA) Q4 2024 Earnings Call Highlights: Revenue Growth Amidst Challenges - Feb 14th, 2025 12:20 am